Drug
Cobicistat mixture with darunavir clinical trials
- studies test it
- 12
- open now
- 0
- in phase 3
- 3
- first study started
- 2009
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
12 studies that test it; most in 2015 (4)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 6
- Phase 2
- 1
- Phase 3
- 3
- Phase 4
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 8
National Institutes of Health Clinical Center (CC) (2) · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (2) · St Stephens Aids Trust (2) · Janssen Pharmaceutical K.K. (1) · Gilead Sciences (1) · Janssen Scientific Affairs, LLC (1) · ViiV Healthcare (1) · Therapeutic Concepts (1)
Often tested with
Tested in the same studies.
Darunavir (4) · Cobicistat (2) · Ritonavir (2) · Etravirine (2) · Rilpivirine (2) · Dolutegravir (2) · Rivaroxaban (1) · Isoniazid (1)
Studies
Open first, then newest update. How each study uses cobicistat mixture with darunavir is read from its arms, and is right about nine times in ten.
Testing it · 12
- A Study to Evaluate the Pharmacokinetics (PK) of Darunavir (DRV) and Cobicistat (COBI) After a Single Oral Administration of Darunavir/Cobicistat Fixed-Dose Combination in Healthy Japanese Adult ParticipantsCompletedPhase 4Janssen Pharmaceutical K.K.NCT03123848Written as Darunavir/Cobicistat
- Impact of Steady State Cobicistat and Darunavir/Cobicistat on the Pharmacokinetics and Pharmacodynamics of Oral Anticoagulants (Rivaroxaban, Apixaban) in Health VolunteersCompletedPhase 1National Institutes of Health Clinical Center (CC)NCT03864406Written as Darunavir/Cobicistat
- Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted With Cobicistat in Healthy VolunteersCompletedPhase 1National Institutes of Health Clinical Center (CC)NCT02771249Written as darunavir/cobicistat (DRV/c)
- EFFICACY AND SAFETY OF A SIMPLIFICATION STRATEGY BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS OPTIMIZED TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS CARRYING ARCHIVED MULTIDRUG RESISTANCE MUTATIONSCompletedPhase 4Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la CienciaNCT03683524Written as Dolutegravir (DTG) plus Darunavir/cobicistat (DRV/cobi).
- Darunavir/Cobicistat and Dolutegravir to Maintain Virologic Suppression and Reduce NRTI-associated ToxicityWithdrawnPhase 2/3Stanford UniversityNCT02499978Written as Darunavir/Cobicistat
- Study to Evaluate the Safety and Efficacy of Switching From Regimens Consisting of Boosted Atazanavir or Darunavir Plus Either Emtricitabine/Tenofovir or Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed HIV-1 Infected AdultsCompletedPhase 3Gilead SciencesNCT02603107Written as DRV/co
- A Single-arm, Open-label, Study to Assess the Pharmacokinetics of Darunavir and Ritonavir, Darunavir and Cobicistat, Etravirine, and Rilpivirine in HIV-1 Infected Pregnant WomenCompletedPhase 3Janssen Scientific Affairs, LLCNCT00855335Written as Darunavir/Cobicistat (FDC)
- The Pharmacokinetics of Dolutegravir, Darunavir/Cobocistat When Co-administered in Healthy VolunteersCompletedPhase 1St Stephens Aids TrustNCT03094507Written as Rezolsta
- Clinical Trial to Evaluate Drug-drug Interactions Between Darunavir/Cobicistat and Etravirine in Hiv- Infected PatientsCompletedPhase 1Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la CienciaNCT02818348Written as darunavir/cobicistat
- THE EFFECT OF CYP3A5 GENOTYPE ON THE PHARMACOKINETICS OF MARAVIROCCompletedPhase 1ViiV HealthcareNCT02625207Written as Darunavir/cobicistat (Part 2)
- SSAT067 PK of Atazanavir/Cobicistat and Darunavir/CobicistatCompletedPhase 1St Stephens Aids TrustNCT02589158Written as Rezolsta
- Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve SubjectsStatus unknownPhase 4Therapeutic ConceptsNCT02404233Written as darunavir/cobicistat
Given in every arm · 1 — cobicistat mixture with darunavir is usual care beside what is tested
As the comparator · 2 — what is tested is compared with cobicistat mixture with darunavir
- Effect of Dolutegravir Compared With Darunavir/Cobicistat on the Severity of Neuropsychiatric Effects al 12 Weeks in Antirretroviral Treatment-Naive Adults.Not yet recruitingPhase 4Instituto Mexicano del Seguro SocialNCT06787976Written as Darunavir/Cobicistat (FDC)
- National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) InfectionCompletedPhase 3ANRS, Emerging Infectious DiseasesNCT02987530Written as Darunavir-cobicistat
Codes
What other systems call cobicistat mixture with darunavir · ClinicalTrials.gg INT001464
- MeSH (NLM) C000711687cobicistat mixture with darunavirOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000711687 | cobicistat mixture with darunavir | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.